Navigation Links
El Proyecto Recuperación transforma hemoderivados en medicina para la hemofilia en países en desarrollo
Date:9/26/2013

MONTREAL, September 26, 2013 /PRNewswire/ --

- El Proyecto Recuperación transforma hemoderivados no utilizados provenientes de donantes de sangre en Canadá en medicina para atender la hemofilia en países en desarrollo

En un acto considerado pionero en todo el mundo, las inestimables proteínas residuales de la producción de hemoderivados a partir de donadores canadienses de sangre se están transformando en tratamientos capaces de salvar la vida y los miembros de miles de personas que viven con hemofilia en países en desarrollo.

La hemofilia es un trastorno hemorrágico heredado y que acompaña a quien lo sufre toda la vida, y afecta a alrededor de una de cada 10.000 personas en el mundo. Cerca de 75% de ellas recibe escaso o nulo tratamiento. La hemofilia es uno de los diversos trastornos que no permiten la correcta coagulación de la sangre. Los hemofílicos padecen de prolongadas hemorragias internas derivadas de heridas de aparentemente poca importancia. El sangrado al interior de articulaciones y músculos es sumamente doloroso y puede causar discapacidad, mientras que el sangrado al interior de órganos importantes, como el cerebro, puede provocar la muerte. La hemofilia A (deficiencia del factor VIII) se trata con el factor VIII, proteína necesaria para la coagulación.

La Federación Mundial de Hemofilia (WFH), en asociación con Canadian Blood Services (CBS) y dos fabricantes de hemoderivados, BIOTEST AG y GRIFOLS, anunciarán oficialmente el lanzamiento del Proyecto Recuperación en el marco  del Foro Mundial de la WFH sobre la seguridad y el suministro de productos para el tratamiento de trastornos hemorrágicos en Montreal, Canadá, el 26 de septiembre. Tras 12 años de trabajo, este proyecto de ayuda humanitaria, inicialmente concebido por la Canadian Hemophilia Society (CHS
'/>"/>

SOURCE World Federation of Hemophilia
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. New Annual US$3 Million Fundamental Physics Prize Recognizes Transformative Advances in the Field
2. Transformation Dental Partners Launch Ground Breaking Cavity Prevention Program that Can Lower Tooth Decay Rates by 74%
3. Industry Thought Leader to Present Transformational Opportunities for Industry Adoption of Advanced Analytics at 2013 HIMSS Annual Conference & Exhibition
4. The Pharmabiotic Research Institute (PRI) is Preparing to Publish its First Works on the Therapeutic and Medicinal Potential of Probiotics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 23, 2015  Array BioPharma Inc. (NASDAQ: ARRY ... agreement with Novartis Pharma AG to acquire worldwide rights ... 3 development.  This agreement is conditional on the closing of ... 22, 2014, which are expected to close in the ...
(Date:1/22/2015)... | RBJ today announces the firm brokered a long-term lease ... leading biopharmaceutical company, at Two Ledgemont Center in ... , president, and Brian Cohen , senior vice president, ... at 95 Hayden Ave. Photo - http://photos.prnewswire.com/prnh/20150122/170765 ...
(Date:1/22/2015)... 2015 The laboratory information management systems ... a number of technological advancements due to factors such ... need to integrate healthcare systems, and increasing government support ... system integration. Key players in the market focus on ...
(Date:1/22/2015)... 2015 zFlo Motion , a US ... an exciting product from a new partner. STT-Systems ... the past 15 years, with offerings in the optical-motion capture, ... IMU system (inertial measurement unit), iSen, is opening eyes around ...
Breaking Biology Technology:Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 2Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 3Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 4Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 5Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 6Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 7Transwestern | RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 3Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 43D Motion Capture Just Got Easy 2
... Aug. 7 SGX Pharmaceuticals,(Nasdaq: SGXP ) today announced ... 30, 2008. For the three months ended June 30, 2008, ... of $7.2 million. For,the six months ended June 30, 2008, ... The revenue in the six month period includes $10.8,million of ...
... SOUTH SAN FRANCISCO, Calif., Aug. 7 Anesiva,Inc. (Nasdaq: ... the second quarter and six months ended June 30, ... advance for Anesiva as we,introduced Zingo(TM) in the U.S. ... executive officer. "In addition, I,m pleased,to report that our ...
... Chromos Molecular,Systems Inc. ("Chromos" or the "Company") announced ... (the "Arrangement Agreement") dated,August 6, 2008 with, among ... Chromos, and Modatech Systems Inc. ("Modatech"),pursuant to which ... effect a plan,of arrangement (the "Arrangement") under section ...
Cached Biology Technology:SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 2SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 3SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 4SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 5SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 6SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 7SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 8SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 9Anesiva Announces Second Quarter 2008 Financial Results and Update 2Anesiva Announces Second Quarter 2008 Financial Results and Update 3Anesiva Announces Second Quarter 2008 Financial Results and Update 4Anesiva Announces Second Quarter 2008 Financial Results and Update 5Anesiva Announces Second Quarter 2008 Financial Results and Update 6Anesiva Announces Second Quarter 2008 Financial Results and Update 7Anesiva Announces Second Quarter 2008 Financial Results and Update 8Chromos enters into an Arrangement Agreement 2Chromos enters into an Arrangement Agreement 3
(Date:12/10/2014)... , Dec. 9, 2014  Valencell, a leader in ... seeing a staggering demand from its licensees for highly ... revealed, is not solely coming from fitness and health ... "A wearable is only as useful as ...
(Date:12/10/2014)... 9, 2014 CIE San Diego has launched an innovative ... that enhances care coordination among social service and care providers ... second $1 million grant from the Alliance Healthcare Foundation to ... be recognized as a "Live Well San Diego" partner on ...
(Date:12/10/2014)... , December 9, 2014 ... BCARD Platform   ... meeting scheduling solutions for business-to-business (B2B) events, today ... leader in mobile near-field communication (NFC), Bluetooth low ...
Breaking Biology News(10 mins):Wearable Technology Products Demand Highly Accurate Biometric Technology 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3
... 6 December 2007 Elsevier is pleased to announce ... Leukotrienes & Essential Fatty Acids (PLEFA) will become the ... of Fatty Acids and Lipids (ISSFAL). 2008 ... in 1978 as Prostaglandins and Medicine by the late ...
... could solve the growing energy demands of millions of ... the region,s tensions pertaining to oil supplies through hydroelectric ... untold ecological harm and displace countless people from their ... Global Environmental Issues, Roelof Dirk Schuiling of Utrecht University ...
... in a Fully Flexible ... ISO-Compliant ... Microsystems, Inc., a,pioneering developer of fingerprint imaging and authentication ... Card. This biometrically-authenticated credential,features a fully-embedded biometric system. Fidelica,s ...
Cached Biology News:Dam the Red Sea and release gigawatts 2Fidelica Microsystems Announces Biometrically-Authenticated Smart Card 2
Mouse Anti-Amyloid beta [1-16], clone 6E10, Monoclonal Antibody...
... Development kit contains the basic components required ... measure natural and recombinant mouse Dickkopf homolog-1 ... Each kit contains sufficient materials to run ... that the following conditions are met: ...
HES-1 [Hairy 1], Available Summer 2003...
E1A (adenovirus early region 1)...
Biology Products: